HK1018464A1 - Improved process for obtaining insulin precursors having correctly bonded cystine bridges. - Google Patents

Improved process for obtaining insulin precursors having correctly bonded cystine bridges.

Info

Publication number
HK1018464A1
HK1018464A1 HK99103399A HK99103399A HK1018464A1 HK 1018464 A1 HK1018464 A1 HK 1018464A1 HK 99103399 A HK99103399 A HK 99103399A HK 99103399 A HK99103399 A HK 99103399A HK 1018464 A1 HK1018464 A1 HK 1018464A1
Authority
HK
Hong Kong
Prior art keywords
improved process
insulin precursors
cystine bridges
correctly bonded
obtaining insulin
Prior art date
Application number
HK99103399A
Other languages
English (en)
Inventor
Franz-Josef Rubroeder
Reinhold Keller
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HK1018464A1 publication Critical patent/HK1018464A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK99103399A 1997-08-18 1999-08-06 Improved process for obtaining insulin precursors having correctly bonded cystine bridges. HK1018464A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
HK1018464A1 true HK1018464A1 (en) 1999-12-24

Family

ID=7839275

Family Applications (3)

Application Number Title Priority Date Filing Date
HK99103399A HK1018464A1 (en) 1997-08-18 1999-08-06 Improved process for obtaining insulin precursors having correctly bonded cystine bridges.
HK04104835.7A HK1061870A1 (en) 1997-08-18 2004-07-06 Improved process for obtaining insulin precursors having correctly bonded cystine bridges
HK08107963.0A HK1119449A1 (en) 1997-08-18 2008-07-18 Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK04104835.7A HK1061870A1 (en) 1997-08-18 2004-07-06 Improved process for obtaining insulin precursors having correctly bonded cystine bridges
HK08107963.0A HK1119449A1 (en) 1997-08-18 2008-07-18 Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges

Country Status (21)

Country Link
US (3) US5986048A (id)
EP (2) EP0906918B1 (id)
JP (1) JP4291900B2 (id)
KR (2) KR100537842B1 (id)
CN (3) CN1483831B (id)
AR (1) AR016821A1 (id)
AT (2) ATE217636T1 (id)
AU (1) AU744824B2 (id)
BR (2) BR9803755A (id)
CA (1) CA2245151C (id)
CZ (1) CZ295679B6 (id)
DE (3) DE19735711C2 (id)
DK (2) DK0906918T3 (id)
ES (2) ES2176870T3 (id)
HK (3) HK1018464A1 (id)
HU (2) HU228203B1 (id)
ID (1) ID20717A (id)
PL (1) PL191901B1 (id)
PT (2) PT980874E (id)
RU (2) RU2205836C2 (id)
TR (1) TR199801587A3 (id)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
EP1242610A1 (en) * 1999-12-22 2002-09-25 Novo Nordisk A/S Method for extractive refolding of scrambledsingle-chain polypeptides
US20030212248A1 (en) * 2000-07-12 2003-11-13 Furman Thomas Charles Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
MY143274A (en) 2005-12-22 2011-04-15 Genentech Inc Recombinant production of heparin binding proteins
SG162834A1 (en) 2006-07-14 2010-07-29 Genentech Inc Refolding of recombinant proteins
CN101815944A (zh) * 2007-07-03 2010-08-25 安姆根有限公司 利用包含体干重的蛋白测量
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
NZ586590A (en) 2008-01-09 2012-06-29 Sanofi Aventis Deutschland Insulin analogues or derivatives having an extremely delayed time-action profile
US9296806B2 (en) * 2008-04-30 2016-03-29 Wockhardt Limited Processes for refolding of insulin
HUE037449T2 (hu) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
ES2965209T3 (es) 2009-11-13 2024-04-11 Sanofi Aventis Deutschland Composición farmacéutica que comprende desPro36exendina-4(1-39)-Lys6-NH2 y metionina
EP3831402A1 (de) 2009-11-13 2021-06-09 Sanofi-Aventis Deutschland GmbH Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US20180282405A1 (en) * 2012-08-05 2018-10-04 Absci, Llc Cytoplasmic expression system
EP2931301B2 (en) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
KR20140106452A (ko) * 2013-02-26 2014-09-03 한미약품 주식회사 신규한 인슐린 아날로그 및 이의 용도
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
WO2015138548A1 (en) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
DK3229828T5 (da) 2014-12-12 2024-10-14 Sanofi Aventis Deutschland Formulering med fast forhold mellem insulin glargin og lixisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
WO2017040363A1 (en) 2015-09-02 2017-03-09 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
NZ279002A (en) * 1994-12-29 1999-02-25 Bio Technology General Corp Production of recombinant human insulin by folding a proinsulin hybrid polypeptide obtained from a bacterial cell
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
CZ259898A3 (cs) 1999-03-17
DK0906918T3 (da) 2002-09-09
EP0980874A1 (de) 2000-02-23
KR100537842B1 (ko) 2006-03-23
JP4291900B2 (ja) 2009-07-08
HU228203B1 (en) 2013-01-28
HUP9801886A3 (en) 1999-06-28
ES2176870T3 (es) 2002-12-01
RU2302882C2 (ru) 2007-07-20
DE59803985D1 (de) 2002-06-06
KR100574580B1 (ko) 2006-04-28
DE59804121D1 (de) 2002-06-20
PL191901B1 (pl) 2006-07-31
PT906918E (pt) 2002-10-31
US6727346B2 (en) 2004-04-27
KR20050067371A (ko) 2005-07-01
HK1119449A1 (en) 2009-03-06
US20020156234A1 (en) 2002-10-24
PT980874E (pt) 2002-10-31
DE19735711C2 (de) 2001-04-26
HU228161B1 (en) 2013-01-28
BR9803755A (pt) 2000-03-28
KR19990023651A (ko) 1999-03-25
CN1483831B (zh) 2012-06-13
EP0980874B1 (de) 2002-05-02
BRPI9816233B8 (pt) 2021-05-25
RU2205836C2 (ru) 2003-06-10
ID20717A (id) 1999-02-18
US5986048A (en) 1999-11-16
CN101186940A (zh) 2008-05-28
AU744824B2 (en) 2002-03-07
HU9801886D0 (en) 1998-10-28
AU8076398A (en) 1999-02-25
DE19735711A1 (de) 1999-02-25
CN1209437A (zh) 1999-03-03
BRPI9816233B1 (pt) 2016-09-27
PL328108A1 (en) 1999-03-01
AR016821A1 (es) 2001-08-01
CN1483831A (zh) 2004-03-24
EP0906918A2 (de) 1999-04-07
CA2245151C (en) 2009-10-06
CN101186940B (zh) 2012-02-08
CA2245151A1 (en) 1999-02-18
JPH11130798A (ja) 1999-05-18
CN1132845C (zh) 2003-12-31
ES2177178T3 (es) 2002-12-01
HUP9801886A2 (hu) 1999-01-28
HU0600287D0 (en) 2006-05-29
US6380355B1 (en) 2002-04-30
EP0906918B1 (de) 2002-05-15
ATE217636T1 (de) 2002-06-15
HK1061870A1 (en) 2004-10-08
CZ295679B6 (cs) 2005-09-14
DK0980874T3 (da) 2002-08-19
TR199801587A2 (xx) 1999-03-22
ATE217012T1 (de) 2002-05-15
EP0906918A3 (de) 1999-08-11
TR199801587A3 (tr) 1999-03-22

Similar Documents

Publication Publication Date Title
HK1018464A1 (en) Improved process for obtaining insulin precursors having correctly bonded cystine bridges.
ZA981343B (en) Sulfonylurea-glitazone combinations for diabetes
EP1010432A4 (en) REMEDIES FOR DIABETES
ZA99104B (en) Method for administering ASPB28-human insulin.
ZA989767B (en) Novel compounds.
ZA9811911B (en) Aryl fused azapolycyclic compounds.
EP0670413A3 (en) Quick connector for cementing head.
HK1025746A1 (en) Syringe.
EP0987332A4 (en) METHOD FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS
ZA985374B (en) Specific C-peptide determination method.
GB9711124D0 (en) Novel cyanoguanidines
EP1026255A4 (en) PROCESS FOR THE PREPARATION OF XYLITOL
HK1056360A1 (en) Process for preparing pesticidal intermediates.
GB9711119D0 (en) Novel cyanoguanidines
ZA9811572B (en) Novel anti-diabetic composition.
EP0999848A4 (en) CHIMEAN PROTEINS FOR TREATING DIABETES
GB9711122D0 (en) Novel cyanoguanidines
GB9711127D0 (en) Novel cyanoguanidines
ZA985561B (en) Process for preparing 4-substituted-1H-Indole-3-Glyoxamides.
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
EP1026254A4 (en) METHOD FOR PRODUCING XYLITOL
ZA982255B (en) Process for the preparation of arylmalonates.
CY2478B1 (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids.
ZA982449B (en) Process for preparing 1-Alkyl-4-(2-chloro-3-alkoxy-4-alkylsulfonylbenzoyl)-5-hydroxypyrazole and related compounds.
ZA98868B (en) Novel compounds.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180816